Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis.

BMC Infect Dis · 2025 · PMC12577339 · PMID 41174563

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significant trendsno p-value reported

Pairwise meta-analyses revealed borderline significant trends towards higher clinical success rates when omadacycline was compared with linezolid in mITT/ITT and CE populations (Table S8).

also in 14 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.